Accenture & Oracle Enhance the Accenture Life Sciences Cloud for R&D with the Introduction of an End-to-End Clinical Data Man...
April 22 2015 - 8:33AM
Business Wire
Accenture (NYSE:ACN) has expanded the Accenture Life Sciences
Cloud for Research and Development (R&D) powered by Oracle with
the addition of enhanced clinical data management capabilities.
This enables life sciences companies to generate high-quality,
reliable and statistically sound data from clinical trials to
reduce the time, effort and cost needed to take drugs from
development to market.
This latest version of the Accenture Life Sciences Cloud for
R&D offers the Oracle Health Sciences Data Management Workbench
(DMW), which includes prebuilt integrations to the Oracle Health
Sciences InForm, an electronic data capture (EDC) solution to
create an end-to-end clinical data collection and management
platform.
With the addition of the Oracle Health Sciences DMW, the
Accenture Life Sciences Cloud for R&D automates the
time-consuming and resource-intensive manual processes required to
load, transform and clean trial data. Trial sponsors and contract
research organizations will now be able to increase the speed and
accuracy of data collection, integration and analysis; achieve
greater efficiency of clinical workflow and query management; and
accelerate stakeholders’ access to data across the trial lifecycle
from source to submission.
The Oracle Health Sciences DMW provides the Accenture Life
Sciences Cloud for R&D with several key benefits,
including:
- Optimized clinical data management
through reusable workflows for easier global clinical trial setup
and implementation;
- Simplified integration with disparate
data providers such as CROs and central labs;
- Improved submissions by more quickly
delivering clean, structure-ready and validated data for
biostatistical analysis; and
- More-efficient clinical operations,
with advanced mechanisms facilitating operational re-use to
streamline cleansing and transformations based on industry
standards.
Additionally, the Oracle Health Sciences DMW in the Accenture
Life Sciences Cloud for R&D is pre-integrated with the Oracle
Health Sciences InForm EDC platform. The latest release of InForm,
version 6.1, enables fully integrated capabilities including coding
and IRT, rapid and reliable trial builds, and one-click,
self-service deployment, including mid-study changes. As a result,
life sciences organizations gain a seamless flow of data, from
electronic data capture to data management to analysis.
“Being able to take advantage of new technologies for clinical
data management in combination with Oracle InForm is a key factor
to helping our clients bring life-improving medicines to patients
faster,” said Kevin Julian, managing director of Accelerated
R&D Services, Accenture Life Sciences. “This latest version of
Accenture Life Sciences Cloud for R&D harnesses the highly
differentiated capabilities of a pre-integrated end-to-end clinical
R&D platform based on leading technology from Oracle.”
The combined solution from Accenture – a Diamond-level member of
Oracle PartnerNetwork – and Oracle bring together Oracle’s
experience in developing and hosting mission-critical clinical data
warehousing and analytics applications for life sciences with
Accenture’s proven implementation capabilities to deliver
service-based solutions.
“As the industry’s only true end-to-end data management solution
in a single environment, Oracle Health Sciences Data Management
Workbench accelerates the speed and accuracy of clinical data
integration, reconciliation, aggregation, and analysis by reducing
time -consuming manual processes required to load, transform, and
clean trial data. Accenture’s Life Sciences Cloud for R&D with
Data Management Workbench is changing the way technology is
developed and delivered across the life sciences industry, helping
life sciences organizations provide life-improving therapies faster
and at a lower cost,” said Steve Rosenberg, general manager of
Oracle’s Health Sciences Global Business Unit. “We at Oracle are
proud that our industry-leading cloud solutions are at the heart of
this leading capability.”
As previously announced in October, the Life Sciences Cloud
Coalition is a ground-breaking initiative, in parallel with the
Accenture Life Sciences Cloud for R&D platform, to build an
assembly of like-minded leaders, collaborating for a healthier
industry in non-competitive areas. The focus of the coalition is on
driving innovation in the Accenture Life Sciences Cloud to
digitally enable the R&D function, speed the drug
development process while improving quality and cost for the
industry. Members of the Life Sciences Cloud Coalition include
Accenture, Oracle, Eisai, Pfizer, Merck, and other leading
pharmaceutical companies.
About Accenture
Accenture is a global management consulting, technology services
and outsourcing company, with more than 323,000 people serving
clients in more than 120 countries. Combining unparalleled
experience, comprehensive capabilities across all industries and
business functions, and extensive research on the world’s most
successful companies, Accenture collaborates with clients to help
them become high-performance businesses and governments. The
company generated net revenues of US$30.0 billion for the fiscal
year ended Aug. 31, 2014. Its home page is www.accenture.com.
TrademarksOracle and Java are registered trademarks of Oracle
and/or its affiliates.
AccentureCam Granstra, + 1 312 693
5992cameira.l.granstra@accenture.com
Accenture (NYSE:ACN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Accenture (NYSE:ACN)
Historical Stock Chart
From Sep 2023 to Sep 2024